Xpert® Xpress Flu/RSV

Home / Tests / Respiratory

Rapid detection and differentiation of Flu A, Flu B, or RSV in as soon as 20 minutes.^{^}

Test pack size(s)

10 Tests

XPRSFLU/RSV-CE-10

Qty

Unit price

Subtotal

USD

Collection devices

Copan 305CN (Nasopharyngeal Swab) (Pack of 50)

305C

Qty

Unit price

Subtotal

USD

Copan 346N (Nasal Swab) (Pack of 50)

346C

Qty

Unit price

Subtotal

USD

Total

Error adding items to cart. If this error persists, please contact Digital Support

List name

Label

Having trouble? Contact Cepheid Digital Support

The Need

In patients of all ages, influenza and RSV often present with similar clinical symptoms, making it difficult to differentiate between the two infections¹
Sensitivities of Rapid EIA Flu tests range from 50-70%²
Sensitivities of Rapid Antigen RSV tests average 29% in adults³
Both Rapid EIA and Antigen manufacturers suggest confirming negative results with RT-PCR or culture²
Rapid RSV tests may have age limitations⁴

(1) Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3)Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
(4) BD Veritor™ System –For Rapid Detection of Flu A+B. Package Insert. DB. Dublin, Ireland. 2014.

The Solution

Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes*
Enables healthcare providers to quickly deliver targeted therapies
Steamlines laboratory operations
Improves patient satisfaction

* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.

The Impact

Single-test confidence will accelerate your laboratory's workflow with on-demand, random-access flexibility. Combine performance with the capability to run other Xpert^® tests (including GBS, MRSA, C. difficile, CT/NG, and MTB/RIF) on Cepheid's GeneXpert^® System to achieve proven productivity increases in overall laboratory service.^5-9
Be Proactive
Achieve rapid results and improve patient management
Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
Quickly deliver targeted therapies and increase peace of mind for patients

* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.
^{^} For positive results with Flu only or RSV only reporting
(5) Morgan MG. The Perfect Storm. Cepheid Impact. 2012 Jun;2:4-7.
(6) Parada JP. Increase Revenue and Improve Patient Safety. Cepheid Impact. 2012 Jun;2:8-11.
(7) El Helali N. Less Uncertainty - Better Safety - More Healthy Newborns. Cepheid Impact. 2012 Jul;3:4-7.
(8) Haynes L. The C. difficile Challenge. Cepheid Impact. 2012 Jul;3:10-15.
(9) Parada JP. Improving Patient Safety. Cepheid Impact. 2012 Oct;4:8-11.